Semaglutide FDA Approvals and Warnings: Full Timeline
Fda semaglutide: what happened, what it means for patients, and where to read the record.
- Active ingredient
- semaglutide
- Manufacturer
- Novo Nordisk
Wegovy overview
Its half-life is about 1 week. At 7 d, half is gone. After five half-lives (35 d), about 3% remains.
In STEP 1, after 68 weeks, the result was 14.9% of body weight versus 2.4% on placebo.
The maker's price page lists monthly price points in US dollars for both its list price and self-pay offers.
Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.